Low-dose hydralazine reduces albuminuria and glomerulosclerosis in a mouse model of obesity-related chronic kidney disease

Larkin, BP; Nguyen, LT; Hou, M; Glastras, SJ; Chen, H; Faiz, A; Chen, J; Wang, R; Pollock, CA; Saad, S

Saad, S (通讯作者),Royal North Shore Hosp, Kolling Inst Med Res, Renal Res Lab, Level 9, St Leonards, NSW, Australia.

DIABETES OBESITY & METABOLISM, 2022; 24 (10): 1939

Abstract

Aim To determine, using a mouse model of obesity, whether low-dose hydralazine prevents obesity-related chronic kidney disease (CKD). Methods From 8 w......

Full Text Link